For patients taking medications that don't work as expected or pharmaceutical companies struggling with clinical trial failures, MetaOmics-10T represents a new starting point.

Building a culture of compliance around respiratory protection no longer relies on guesswork. CleanSpace is making it ...

DUBAI – In a solid executive action that is in accordance with the UAE's National Strategy for Artificial Intelligence 2031, ...

Researchers are cautioning against relying solely on glycated haemoglobin, ‘HbA1c’, for diagnosing and monitoring diabetes in ...

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.

For decades, medical research has treated the human genome as the master blueprint for understanding disease. But a growing body of evidence suggests that what happens outside our cells, the sum total ...

Pancreatic ductal adenocarcinoma is one of the most lethal cancers, in large part because it usually stays hidden until it ...

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...

Every living organism has its own genetic "blueprint": the source code for how it grows, functions and reproduces. This blueprint is known as a genome. When scientists sequence a genome, they identify ...

Conditional genetics and single-embryo RNA-seq show that SETDB1 extinguishes the transient, retroelement-driven transcriptional programs of the totipotent two-cell state to facilitate the exit from ...

Scientists have created the most detailed maps yet of how genes control one another inside the brains of people with Alzheimer’s disease. Using a powerful new AI-based system called SIGNET, the team ...

Key points Genomics delves into the genetic make-up of organisms, which helps us understand how they work.With new ...